420 with CNW — US Supreme Court Sets Dates to Hear Marijuana Users’ Gun Rights Case

The United States Supreme Court has set a date to hear arguments in a closely watched case that could determine whether federal restrictions on gun ownership for people who use cannabis are constitutional.

The justices scheduled oral arguments for March 2, roughly two months after agreeing to review the dispute. The case pits the Department of Justice (DOJ) against Ali Danial Hemani, who was prosecuted under a federal statute that bars individuals who use illegal drugs from purchasing or possessing firearms. Hemani argues that the law violates the Second Amendment.

At issue is a provision of federal law, codified as 18 U.S.C. § 922(g)(3), which has been under increasing scrutiny in lower courts. In Hemani’s case, a federal appeals court ruled that applying the ban to people who use cannabis infringes on constitutional gun rights. That decision created further division among federal courts, prompting the Supreme Court to step in.

Support for the government’s position has come from a broad group of state officials. Attorneys general from 19 states, along with Washington, D.C., filed a brief urging the justices to preserve the statute. They argue that the law plays a crucial role in maintaining public safety and aligns with historical limitations on firearm possession.

Groups that support tighter gun regulations, including the Brady Center, Everytown for Gun Safety, Giffords Law Center, and others, have asked the court to reverse the lower court’s ruling. A separate filing from a coalition of legal and history scholars contends that restrictions on armed individuals viewed as dangerous have longstanding roots in American law.

Smart Approaches to Marijuana and more than 20 similar groups urged the court to uphold the federal ban, arguing that cannabis consumption can be linked to impaired judgment, violence, and mental health risks.

In filings with the court, Solicitor General D. John Sauer argued that people who use illegal substances present a higher risk than those who consume alcohol.

In an earlier filing related to Hemani, the DOJ noted that federal appeals courts are deeply divided on the issue. Prosecutors also highlighted Hemani’s background as a dual U.S. and Pakistani citizen, alleging connections to Iranian-linked entities that had drawn the attention of federal investigators.

The case comes during a period of shifting federal cannabis policy. President Donald Trump recently signed an executive order instructing AG Pam Bondi to complete a process that would move cannabis from Schedule 1 to Schedule 3 under the Controlled Substances Act. Legal experts say it remains unclear whether that change would have any direct effect on gun cases tied to marijuana use.

The Supreme Court’s eventual ruling could shape the outcome of several similar cases nationwide. If the justices uphold the statute, the government would likely prevail in other pending disputes. The court has already declined to hear appeals in some related cases, while others remain unresolved.

The marijuana industry, including entities like Curaleaf Holdings Inc. (CSE: CURA) (OTCQX: CURLF), will be watching how the Supreme Court rules in this case and what precedent will be set by that decision.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Buying Habits of Gen Z’s Are Changing Marijuana Retail

Cannabis retailers across the U.S. are adjusting to an unexpected shift in shopper behavior as the youngest legal buyers reshape the market. Gen Z customers are coming into stores, but they are approaching cannabis with more intention, more research, and more caution than many of the shoppers who came before them.

Los Angeles’ The Higher Path & The Other Path director Adrienne Airhart says customers are not walking in to chase intense highs. According to her, younger adults often use THC to support workouts, manage school workloads, or ease social discomfort. For many of them, cannabis has become another tool in a daily routine rather than an escape vehicle.

For years, many retailers assumed younger adults would consume less cannabis and that growth would come from older demographics. But Gen Z’s approach is presenting a new opening. It is not tied to high-volume use. It is tied to consistency, intentionality, and a desire for reliable effects.

Recent consumer surveys reveal clear differences between age groups. Adults 50 and older continue to adopt marijuana at fast rates and often look for help with sleep, relaxation, pain, or mental health. Millennials remain the most active spenders, buying across a wide range of products that deliver comfort and convenience, such as topicals, vapes, edibles, and affordable flower.

Gen Z, shaped by wellness trends and rising awareness around anxiety, is coming up during a period where many young adults drink less than previous generations.

National polling, including Gallup findings, shows younger consumers prefer substances that feel cleaner, are easier to regulate, and are compatible with daily life. Cannabis fits neatly into that shift.

Financial strain also plays a significant role. High housing costs, inflation, and lingering student loans leave this group with limited discretionary money. They visit stores less frequently and choose smaller baskets.

Surveys show most adults (69%) aged 18 to 24 favor marijuana over alcohol, and many say they are replacing alcohol with lower-dose THC options, such as beverages and edibles. They also plan consumption around specific situations and emphasize consistency over intensity.

Retailers have started adjusting their shelves accordingly. The Higher Path added a low-dose shelf in response to growing interest in mild, easy-to-manage products.

Larger multipacks of prerolls still sell, but often to groups seeking light social effects rather than a strong high. Gen Z buyers have not abandoned potency, yet they increasingly want it delivered in formats that feel controlled and purposeful.

Since only part of Gen Z is old enough to buy legally, experts say these habits are early indicators of what the future market may look like. Retailers who invest in education, effect-based merchandising, and products that fit structured routines may benefit from steady demand as this generation gains more buying power.

Operators say the opportunity is not in waiting for heavy consumption to return. It lies in adapting to a consumer base that values purpose, control, and thoughtful use. For companies like Curaleaf Holdings Inc. (CSE: CURA) (OTCQX: CURLF), the changing preferences of different demographics of consumers is something that will determine product design and marketing for years to come.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Trump Supports Hemp THC Ban in Spending Bill Reopening Government

The U.S. Senate’s recent approval of a broad spending bill to end the longest federal government shutdown includes a measure that would prohibit hemp-derived THC products, marking a major shift in national cannabis policy since the passage of the 2018 Farm Bill.

The proposal, which has now been signed into law, seeks to close what lawmakers describe as a loophole that has allowed intoxicating hemp products to flourish outside state-regulated marijuana markets. While Senator Rand Paul(R) attempted to strike the new language from the legislation, the White House indicated that President Trump supported the measure.

The debate represented another chapter in an ongoing fight over hemp-derived THC products such as Delta-8 and THCA flower. These products, which can produce the same psychoactive effects as marijuana, are being sold widely online and in convenience stores across the country. Critics argue they exploit the Farm Bill’s definition of hemp, allowing unregulated marijuana to be sold under the guise of legality.

Major retailers have started stocking hemp-based THC drinks even as opponents, including state-regulated cannabis industry groups and prohibition advocates, warn of potential risks to public health. Alcohol industry representatives have also weighed in, with leading trade associations announcing their support for the ban.

Hemp industry leaders, however, warn that the ban could devastate hemp producers. The U.S. Hemp Roundtable noted that the language could effectively eliminate most of the $28 billion hemp market.

The Senate Appropriations Committee stated that the measure would halt sales of intoxicating hemp-based products, including Delta-8 THC, while maintaining the legality of non-intoxicating industrial hemp and CBD.

The revised definition of hemp limits THC content, including its acidic precursor THCA, to no more than 0.3% by dry weight. It also excludes compounds not naturally produced by the marijuana plant or those synthesized in a lab, such as HHC and THC-P.

Now that it has been enacted, the rule bans most hemp-derived drinks currently sold in stores and bars, allowing only products with no more than 0.4 milligrams of THC per serving.

Senator Paul had urged colleagues to vote on an amendment that would remove the restrictive language, despite his actions likely putting him at odds with Trump. Meanwhile, representatives from major alcohol trade associations, including the Beer Institute and Wine Institute, pressed senators to reject Paul’s proposal, warning that his actions could jeopardize efforts to reopen the government.

For the regulated cannabis industry, the move is a win, seen as a long-overdue step toward aligning federal law with current market realities.

Marijuana industry players like Curaleaf Holdings Inc. (CSE: CURA) (OTCQX: CURLF) will be watching how the marijuana and hemp retail landscape is reshaped by this newly passed law.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Teens Who Use Marijuana Before 15 Likely to Exhibit Problems Later

Teenagers who begin using marijuana before the age of 15 face a significantly greater likelihood of using the drug more frequently later in life and of developing physical and mental health issues as young adults, according to new research published in JAMA Network Open.

The study, conducted by researchers in Montreal, draws on data from the Québec Longitudinal Study of Child Development, a decades-long project tracking more than 1,500 participants from birth into early adulthood. The goal was to understand how early cannabis habits might influence long-term health outcomes.

Researchers found that 60 percent of teens in the study never used marijuana during adolescence. Of those who did, half began experimenting in their later teen years and reported occasional use by age 17.

The remaining 20 percent, who started using before turning 15, were far more likely to use marijuana regularly by the time they reached 17. This group also showed higher rates of medical visits for physical and psychological concerns once they reached adulthood.

“The risk is concentrated among those who begin early and use often,” said Massimiliano Orri, a psychologist at McGill University and the study’s lead author.

According to the study, early marijuana users were more likely (51%) to seek mental health care in young adulthood, even after accounting for factors such as family conflict, peer relationships, and parental supervision. They were also 86 percent more likely to need treatment for physical health issues, with respiratory problems, accidents, and injuries among the most commonly reported conditions.

Previous studies have also linked early marijuana use to mental health challenges. Columbia University psychiatrist Dr. Ryan Sultan, who has conducted related research, found that adolescents who use marijuana recreationally are 2 to 4 times more likely to develop psychiatric disorders. Other studies have connected early use to psychosis, poor school performance, and truancy.

Experts note that the adolescent brain continues to develop well into the mid-twenties, particularly in regions responsible for decision-making, impulse control, and emotional regulation. Regular marijuana use during this stage, they say, can interfere with that process.

Sultan added that teens who rely on cannabis to manage anxiety or mood may weaken their natural coping abilities over time, which can increase the risk of developing chronic mental health disorders. For that reason, he advises young people and their parents to delay cannabis use until around age 25, when the brain has matured further and the potential health risks are lower.

The policy changes made to legalize the substance and license companies like Curaleaf Holdings Inc. (CSE: CURA) (OTCQX: CURLF) could provide an avenue through which teens and younger adults can be prevented from accessing marijuana through age-verification checks conducted at retail outlets so that the risks indicated in this research are minimized.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Missouri Regulators Consider Authorizing Marijuana Curbside Pickup

Missouri cannabis dispensaries could soon have another way to serve customers, as state regulators consider a rule that would permit curbside pickup. The proposal would expand the current options, which already include delivery and drive-thru services with state approval.

The state Division of Cannabis Regulation this week released a draft amendment that outlines how dispensaries could implement curbside pickup. The agency is inviting public comments on the proposal through October 28 before deciding whether to move forward.

For some dispensary owners and cannabis customers, the change could make a big difference. Mark Hendren, CEO of Flora Farms, one of Missouri’s largest cannabis companies, said curbside service would help customers who have mobility challenges. Three of Flora Farms’ eight dispensaries currently lack drive-thru windows, which means every visitor must park, walk inside, and go through standard check-in procedures.

“When customers visit our stores, they have to get out of their vehicles and go through the normal check-in inside the building,” Hendren said. “That process can be challenging for some of our customers with disabilities, so this would really help them.”

Under the draft rules, curbside pickup would operate under strict security and payment guidelines. Customers would have to complete their transactions online in advance, ensuring no cash is exchanged outside the dispensary. The designated pickup areas would also need to be monitored by security cameras, similar to those required for existing drive-thru cannabis lanes.

Dispensaries would additionally be required to display a clear warning sign reminding customers that it is illegal to operate a boat, motor vehicle, or aircraft while under the influence of cannabis.

The draft amendment released on Tuesday is still in the early stages and has not yet been incorporated into the state’s formal rulemaking process. According to the state Department of Health and Senior Services (DHSS), which oversees the Cannabis Regulation Division, the move is meant to gather input from both industry members and the public before the agency submits an official rule change.

“This step is part of DHSS’s ongoing process to consider all perspectives before filing new or amended regulations,” the department said in a statement.

According to the department’s statement, the goal of the amendment is to improve how dispensaries operate by making cannabis purchases more accessible. The agency said the curbside option would particularly benefit medical patients, caregivers, and consumers with physical limitations who might struggle with in-person transactions.

Such helpful changes are likely to be applauded by players like Curaleaf Holdings Inc. (CSE: CURA) (OTCQX: CURLF) in the wider marijuana industry around the region.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Does Marijuana Prohibition at the Federal Level Prevent Employee Unionization?

A marijuana business in Michigan is arguing that federal labor laws should not apply to marijuana employees since cannabis remains illegal under U.S. law in an attempt to block unionization.

The company, Exclusive Brands, based in Ann Arbor, recently made this case to the National Labor Relations Board (NLRB). If the board accepts the argument, it could weaken protections for workers in the fast-growing $32 billion cannabis market. Observers say this could be the first time a marijuana company has used federal prohibition as a reason to block union efforts.

For years, the NLRB has recognized cannabis employees’ rights under the National Labor Relations Act (NLRA). Reversing that stance would mean overturning its own precedent. Lauren McFarran, a former NLRB chair, described such a shift as a major departure. Still, some experts believe a Trump-era board could be open to such a move, given the administration’s record of limiting worker protections.

At the moment, the NLRB cannot act because it lacks the quorum needed to issue decisions. Until new appointments are made, labor disputes fall under state law, leaving cannabis workers and employers facing a confusing mix of rules depending on where they operate.

Tensions are already high in Michigan, where eight employees from Exclusive Brand have been on strike since late August. They voted to join the United Food and Commercial Workers union, but the company has refused to recognize their choice. Budtender Emily Hull, part of the organizing team, accused the company of cutting hours in retaliation against outspoken staff. According to Hull, Exclusive has also ignored attempts to negotiate.

Josh Leadford, the company’s attorney, filed a petition with the NLRB in early August. His filing claimed that because cannabis is classified as a Schedule I drug, neither Exclusive nor the union can seek protection or enforcement through the board. Notably, the petition did not cite prior case law. A hearing has yet to be scheduled.

Historically, even GOP-appointed panels have agreed that the NLRA applies to marijuana businesses. But if the NLRB remains in limbo, states may step in. Some states, such as California, Massachusetts, and New York, allow workers to appeal to state labor boards if the federal board cannot act. In conservative states with weaker labor regulations, however, cannabis companies might benefit.

Marijuana employees already face gaps in protection. Federal law excludes agricultural workers from the NLRA, which means many cultivation staff are left out unless their state has its own laws, as in California. Unions gained traction in the industry under Biden’s administration, with Arizona seeing its first agricultural unionization in decades.

However, major operators like Green Thumb and Curaleaf Holdings Inc. (CSE: CURA) (OTCQX: CURLF) have fought hard against union efforts in both the courts and before the NLRB.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Governor Abbott Signals Texans to Await Action on THC-Rich Hemp Products

Texas Governor Greg Abbott has hinted that more action could soon be taken on THC-infused hemp products, despite lawmakers failing to move the issue forward this year.

Speaking on Friday, Abbott suggested the discussion is far from over and told reporters to “stay tuned” when asked whether he would wait until the 2027 regular session or call another special session as early as next year.

While some Republican legislators have pushed for a full ban on intoxicating hemp products, Abbott has resisted that approach. Instead, he has leaned toward rules centered on age restrictions and protecting public health. Earlier in the year, he vetoed a measure that would have outlawed THC-infused hemp products entirely.

The state’s special legislative sessions were primarily called for election redistricting measures, but both also featured bills targeting THC-infused hemp products. In August, during the second special session, the Senate again passed a hemp ban and sent it to the House. But progress stalled as many Democratic representatives left the state to block a redistricting measure, preventing the chamber from taking up the hemp legislation.

Abbott has stated that he is open to a revised plan, but not one that shuts down the industry completely. His stance has placed him at odds with Lieutenant Governor Dan Patrick and Senator Charles Perry, the bill’s sponsor, who argue that banning THC-infused hemp products is necessary for public safety.

Supporters of regulation, on the other hand, maintain that the state should focus on preventing youth access while continuing to allow adults 21 and over to purchase and use hemp responsibly.

Democratic lawmakers also introduced alternative measures. Representative Nicole Collier proposed HB 42, a short bill aimed at protecting consumers who unknowingly purchase hemp items that test above legal THC limits. The measure would prevent criminal charges if a person bought what they reasonably thought was a legal hemp product from a licensed retailer.

Representative Jessica González filed HB 195, which would go further by legalizing cannabis for adults 21 and over, permitting possession of up to 2.5 ounces, with stricter limits on concentrates. Another proposal, HB 198, called for a state-led study on testing methods to detect THC impairment.

Separately, the Texas Department of State Health Services has moved forward with proposed rules to broaden medical marijuana access, including allowing doctors to recommend cannabis for additional conditions and setting standards for approved inhalation equipment.

Major players in the marijuana industry, such as Curaleaf Holdings Inc. (TSX: CURA) (OTCQX: CURLF), will be monitoring how the push to legalize adult-use marijuana in Texas progresses.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — The Supreme Court Could Advance Marijuana Reform Amid Trump’s Inaction

The future of federal cannabis policy is once again in uncertainty as the Trump administration sends mixed signals on marijuana reform. On one hand, Trump has voiced support for medical marijuana and hinted that he may consider reclassifying it.

On the other hand, the Department of Justice (DOJ) is actively working to defend cannabis prohibition in court while also trying to restrict gun rights for cannabis users.

Since Congress has repeatedly failed to move forward on marijuana reform, advocates are now turning their hopes toward the courts and the executive.

The Supreme Court is expected to hear two cases that could reshape marijuana law. The first, USA v. Hemani, involves a Texas man challenging the government’s ban on marijuana users owning firearms. The second, Canna Provisions v. Bondi, questions a 2005 ruling that upheld federal cannabis prohibition and could open a path for reform without waiting on Congress.

This comes as Trump recently signaled interest in reclassifying cannabis as a less harmful substance. However, predicting his approach is difficult given his conflicting decisions, including appointing an anti-marijuana DEA chief and embracing a strict law-and-order stance.

Despite backing medical marijuana on the campaign trail and voting in Florida, Trump has since given the issue little attention, leaving speculation to fill the gaps.

The ruling on the Hemani case could force the administration to state its position more clearly. However, legal scholars note that rescheduling cannabis may not resolve most concerns. If cannabis moves to Schedule III, it would still require FDA approval and a prescription, meaning recreational users would remain in violation of federal law and could still lose gun rights.

Meanwhile, the second case is moving toward the Supreme Court. Multistate cannabis company Verano Holdings, along with other businesses, filed a lawsuit claiming that cannabis’ federal prohibition is unconstitutional.

Their case was rejected by a federal appeals court earlier this year, but their legal team, led by high-profile attorney David Boies, is preparing to petition the Supreme Court. Their goal is to get the court to reconsider the CSA for the first time since 2005.

Observers caution that litigation should not be read as a clear policy direction. They say that DOJ lawyers are obligated to defend existing laws even as federal agencies weigh new policies, such as rescheduling.

The outcome of these cases could force the government to address the distinction between recreational and medical cannabis. Trump himself has suggested that medical use deserves more consideration, while recreational use raises broader concerns.

Marijuana firms across the board, including companies like Curaleaf Holdings Inc. (CSE: CURA) (OTCQX: CURLF), will be following these issues before the Supreme Court to see how the outcomes could impact the trajectory of the industry in the U.S.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Study Finds Home Values Appreciate Faster in States Having Legal Adult-Use Marijuana Markets

Legalizing recreational cannabis is proving to be an economic advantage for states that have adopted it, according to a recent Clever Offers study. The research links marijuana legalization to rising property values and billions of dollars in additional tax income, showing a clear advantage over states that continue to prohibit it.

Between 2009 and 2024, property values in recreational states rose by an average of $222,598, rising from $224,677 to $447,635 according to the study. In contrast, states that continue to prohibit recreational marijuana experienced smaller increases, with prices rising from $158,273 to $320,904, a gain of $162,631. That leaves a gap of more than $60,000 in favor of states with recreational marijuana.

For instance, when Colorado legalized recreational cannabis in 2012, the typical home was valued at a little above $231,000. That figure had climbed to over $568,000 as of 2024, a 146% jump.

While higher prices have made buying harder, sellers and local governments have seen huge benefits, especially with billions in added tax money. Colorado has since become one of the most attractive places to live in the U.S.

Medical-only states also show stronger housing markets than states where cannabis is still banned entirely. Between 2009 and 2024, property values in medical states rose by nearly $195,000, while in states without legalization the increase was closer to $173,000. The difference suggests that even limited legalization can bring economic advantages.

In addition to higher home prices, cannabis sales are filling state budgets. States that taxed cannabis sales collected a combined $4 billion in 2024, with California leading the way by bringing in $1 billion.

Since beginning legal sales, Washington has collected $3.7 billion, Colorado has earned $2.9 billion, and California has pulled in $6.7 billion since its tax system launched in 2018. Medical marijuana taxes, while less widespread, also provide a boost. For example, Oklahoma collected $51 million in 2023 from taxing medical cannabis, and Louisiana brought in $2 million from its program.

Supporters argue the evidence should put to rest claims that cannabis markets harm communities. Instead, legalization appears to support stronger housing markets, safer regulated sales, and tax revenue that can be redirected into public services like infrastructure, education, and safety programs.

As states search for new ways to strengthen budgets and stimulate growth, cannabis legalization—especially for recreational use—continues to prove itself as both a financial opportunity and a community benefit.

The data suggests that states experiencing dwindling tax revenue from licensed firms like Curaleaf Holdings Inc. (CSE: CURA) (OTCQX: CURLF) need to look at the bigger picture of where else related revenue is coming from other than just focusing on the direct tax revenue from marijuana operations.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Proposed Pennsylvania Bill Would Make Employers Cover Medical Cannabis Under Workers’ Compensation

A new bill focusing on medical marijuana and workers’ compensation has been introduced in the Pennsylvania legislature as debate over legalizing recreational cannabis gains momentum. The bill, introduced by Representative David Delloso, would require employers in the state to reimburse injured workers who use medical cannabis as part of their treatment.

Under this proposed law, workers who qualify could get up to $250 each month to help cover the cost of medical marijuana, with a maximum limit of $3,000 per year. The reimbursement would apply only to those using marijuana for certified medical reasons, as approved under the state’s medical cannabis program.

Delloso explained that his bill offers an alternative to opioids for people living with chronic pain after a workplace injury. He pointed out that the ongoing opioid crisis has shown how risky those drugs can be and stressed that his proposal aims to protect workers from that threat.

The representative added that this law would require medical cannabis to be approved by the state’s Department of Health and prescribed under the existing medical marijuana framework. He further argued that the change would not only help workers manage their pain more safely but also ease the emotional and financial burden on their families.

So far, six Democratic lawmakers have signed on as early backers. The bill was sent to the House Labor and Industry Committee for review earlier this week.

Delloso has also been active in efforts to legalize recreational cannabis in the state. His most recent proposal would set up a system where the state controls cannabis sales. However, a similar plan passed in the House was rejected in the Republican-led Senate.

While that broader legalization bill still has a chance to gain traction, some state Democrats are now encouraging voters to put pressure on senators to approve it. They argue that regulating cannabis would boost public safety and create significant revenue for the state.

Although some Republican lawmakers are warming up to the idea, Senate leaders like Joe Pittman have shown little interest. Still, there are signs of change. Senator Dan Laughlin, who partnered with Democrat Sharif Street on a legalization effort, noted that more people now support cannabis reform over raising taxes to fix budget issues.

A recent survey found that most Pennsylvanians would prefer marijuana to be sold by private businesses instead of through government-run stores.

If efforts to have employers reimburse workers who need medical marijuana after workplace accidents succeed, the change will be applauded by the wider marijuana movement, including major companies like Curaleaf Holdings Inc. (CSE: CURA) (OTCQX: CURLF) operating in other states.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com